F
Frank M. Sacks
Researcher at Harvard University
Publications - 520
Citations - 86842
Frank M. Sacks is an academic researcher from Harvard University. The author has contributed to research in topics: Cholesterol & Weight loss. The author has an hindex of 120, co-authored 490 publications receiving 80422 citations. Previous affiliations of Frank M. Sacks include Erasmus University Rotterdam & University of Texas Health Science Center at Houston.
Papers
More filters
Journal ArticleDOI
Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis.
Sarah A. Aroner,Jeremy D. Furtado,Frank M. Sacks,Frank M. Sacks,Michael Y. Tsai,Kenneth J. Mukamal,Robyn L. McClelland,Majken K. Jensen,Majken K. Jensen +8 more
TL;DR: The findings in a multi-ethnic population support the involvement of apoC-III in the development of diabetes, potentially through its association with circulating triacylglycerols.
Journal ArticleDOI
Effects of Lowering Glycemic Index of Dietary Carbohydrate on Plasma Uric Acid Levels: The OmniCarb Randomized Clinical Trial.
Stephen P. Juraschek,Mara McAdams-DeMarco,Allan C. Gelber,Frank M. Sacks,Lawrence J. Appel,Karen White,Edgar R. Miller +6 more
TL;DR: The individual and combined effects of carbohydrate quality and quantity and proportion of total daily energy [percentage of carbohydrates] on uric acid levels are determined.
Journal ArticleDOI
Trans fatty acids in european margarines
Karin B. Michels,Frank M. Sacks +1 more
TL;DR: To the Editor: The content of trans fatty acids in the authors' foods has been causing concern because of reported adverse effects on serum lipid levels and coronary heart disease.
Journal ArticleDOI
Lipid lowering and beyond: Results from the CARE study on lipoproteins and inflammation
Frank M. Sacks,Paul M. Ridker +1 more
TL;DR: Attaining an LDL of <125 mg/dl may be sufficient treatment of LDL concentrations, removing the adverse effect of LDL on coronary events, and raises the possibility that the efficacy of pravastatin may partly result from anti-inflammatory as well as lipid lowering properties.
Journal ArticleDOI
A circadian rhythm-related MTNR1B genetic variant modulates the effect of weight-loss diets on changes in adiposity and body composition: the POUNDS Lost trial.
Leticia Goni,Dianjianyi Sun,Yoriko Heianza,Tiange Wang,Tao Huang,J. Alfredo Martínez,Xiaoyun Shang,George A. Bray,Steven R. Smith,Frank M. Sacks,Lu Qi +10 more
TL;DR: The results suggest that carriers of the G allele of the MTNR1B rs10830963 may have a greater improvement in body adiposity and fat distribution when eating a low-fat diet.